There are several reports of a negative role for CTMP in neuronal survival via reduced Akt signaling in neurological research, and this study suggests it could be a potential target in one of the earliest pathologies documented in ALS. This evidence concerns the gene AKT1 and amyotrophic lateral sclerosis.